A former oncologist discusses how yoga became a vital part of her recovery after a surprise breast cancer diagnosis.
New research sheds lights on the causes of thyroid cancer, overdiagnosis of PTC
Dr. Kevin Kalinsky discusses the role of targeted therapy and clinical decision-making in managing estrogen-driven, HER2-negative breast cancer.
A lung cancer survivor explains how a serendipitous friendship with her stepson’s girlfriend’s aunt changed her life.
PD-1 treatment may help by shifting certain immune cells to fight diseases like kidney cancer; higher CD163-positive TAMs are linked to better outcomes.
After receiving a diagnosis of breast cancer, I received so much support from my family, friends and others.
After receiving a breast cancer diagnosis, I was faced with many people offering “advice” or commentary about the disease.
While one woman always assumed her aunt Judy provided excellent cancer care, she learned it firsthand upon her own diagnosis.
Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment.
A breast cancer survivor explains that many people deal with long-term emotional trauma as a result of their cancer experience and argues that more should be done to address it.
A colleague describes Dr. Edward S. Kim’s devotion to improving lung cancer care and creating more inclusive clinical trial practices.
Dr. Anna Arthur discusses the NOURISH trial, which aims to address food insecurity and malnutrition in patients with blood cancers undergoing treatment.
Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.
Treatment with pyrotinib and the chemotherapies trastuzumab, docetaxel and carboplatin significantly improved response rates over the triplet chemotherapy regimen alone in the neoadjuvant treatment of patients with HER2-positive breast cancer.
I've found that making time for a good laugh each day helped break through the looming thought of cancer.
Twenty-five years ago, I was diagnosed with ovarian cancer, which sparked fears of leaving my loved ones behind.
Initially, we used my husband's diagnosis to show our support as we navigated this journey and joined a new “club” we really didn’t want to be a part of.
Dr. Kandace P. McGuire discusses how targeted axillary staging differs from traditional methods of staging in patients undergoing breast cancer treatment.
Dr. Joshua Sabari and Dr. Nausheen Ahmed sat down to discuss topline takeaways in the realm of hematologic malignancies following the 2025 ASCO Meeting.
Scans for cancer are never easy, especially when waiting for the results, but I’ve found ways to help me through these intimidating moments.
An oncology nurse strives to educate patients and providers to ensure safe cancer treatment.
When triple-negative breast cancer showed up at my door, I did what I could to prepare for the visit.
The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for patients with stage 2 colorectal cancer after surgery.
Patients with gastrointestinal cancer may benefit from multidisciplinary care and open communication with their care team, as per an expert.
I find myself enormously inadequate to fully explain why I think this lady, my wife, should be selected as a Multiple Myeloma Hero, but whether she is or not, she is my hero.
CURE sat down with Dr. Tanja A. Gruber of Stanford Medicine Children’s Health to discuss clinical trials in infant leukemia.
What is Lymphoma - Lymphoma refers to a deadly cancer of your lymphatic system, including the spleen, glands, bone marrow, and lymph nodes (lymph glands).
Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or Xeloda to be aware of it.